Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 408041 - 408060 out of 563565 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Poland | (C09CA07) telmisartan (adm: O) | Telmisartan Bluefish, tabl., 40 mg | 28 szt., 40 mg , 28 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | BluefishPharmaceuticalsAB |
| Poland | (C09CA07) telmisartan (adm: O) | Telmisartan Genoptim, tabl., 40 mg | 28 szt., 40 mg , 28 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | SynoptisPharmaSp.zo.o. |
| Poland | (C09CA07) telmisartan (adm: O) | Telmisartan Bluefish, tabl., 80 mg | 28 szt., 80 mg , 28 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | BluefishPharmaceuticalsAB |
| Poland | (C09CA07) telmisartan (adm: O) | Telmisartan Genoptim, tabl., 80 mg | 28 szt., 80 mg , 28 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | SynoptisPharmaSp.zo.o. |
| Poland | (C09DA03) valsartan and diuretics | Co-Valsacor, tabl. powl., 160+12,5 mg | 56 szt., 160 mg + 12,5 mg , 56 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | Krka,d.d.,Novomesto |
| Poland | (C09DA03) valsartan and diuretics | Co-Valsacor, tabl. powl., 160+25 mg | 56 szt., 160 mg + 25 mg , 56 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | Krka,d.d.,Novomesto |
| Poland | (C09DA03) valsartan and diuretics | Co-Valsacor, tabl. powl., 80+12,5 mg | 28 szt., 80 mg + 12,5 mg , 28 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | Krka,d.d.,Novomesto |
| Poland | (C09DA03) valsartan and diuretics | Co-Valsacor, tabl. powl., 80+12,5 mg | 56 szt., 80 mg + 12,5 mg , 56 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | Krka,d.d.,Novomesto |
| Poland | (C09DA06) candesartan and diuretics | Carzap HCT, tabl., 16+12,5 mg | 28 szt., 16 mg + 12,5 mg , 28 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | Zentiva,k.s. |
| Poland | (C09DA06) candesartan and diuretics | Carzap HCT, tabl., 8+12,5 mg | 28 szt., 8 mg + 12,5 mg , 28 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | Zentiva,k.s. |
| Poland | (C09DA06) candesartan and diuretics | Karbicombi, tabl., 16+12,5 mg | 56 szt., 16 mg + 12,5 mg , 56 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | Krka,d.d.,Novomesto |
| Poland | (C09DA06) candesartan and diuretics | Karbicombi, tabl., 32+12,5 mg | 28 szt., 32 mg + 12,5 mg , 28 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | Krka,d.d.,Novomesto |
| Poland | (C09DA06) candesartan and diuretics | Karbicombi, tabl., 32+25 mg | 28 szt., 32 mg + 25 mg , 28 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | Krka,d.d.,Novomesto |
| Poland | (C09DA06) candesartan and diuretics | Karbicombi, tabl., 8+12,5 mg | 56 szt., 8 mg + 12,5 mg , 56 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | Krka,d.d.,Novomesto |
| Poland | (C09DA07) telmisartan and diuretics | Polsart Plus, tabl., 40+12,5 mg | 28 szt., 40 mg + 12,5 mg , 28 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | ZakładyFarmaceutycznePOLPHARMAS.A. |
| Poland | (C09DA07) telmisartan and diuretics | Polsart Plus, tabl., 80+12,5 mg | 28 szt., 80 mg + 12,5 mg , 28 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | ZakładyFarmaceutycznePOLPHARMAS.A. |
| Poland | (C09DA07) telmisartan and diuretics | Polsart Plus, tabl., 80+25 mg | 28 szt., 80 mg + 25 mg , 28 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | ZakładyFarmaceutycznePOLPHARMAS.A. |
| Poland | (C10AA05) atorvastatin (adm: O) | Atoris, tabl. powl., 40 mg | 90 szt., 40 mg , 90 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | Krka,d.d.,Novomesto |
| Poland | (C10AA05) atorvastatin (adm: O) | Torvacard, tabl. powl., 80 mg | 30 szt., 80 mg , 30 tabl. | Retail price with vat |
$0-0 |
$0-0 |
n/a | Zentiva,k.s. |
| Poland | (C10AB05) fenofibrate (adm: O, micronised) | Fenardin, kaps. twarde, 160 mg | 30 szt., 160 mg , 30 kaps. | Retail price with vat |
$0-0 |
$0-0 |
n/a | BauschHealthIrelandLtd. |
